A new membrane-bound OprI lipoprotein expression vector high production of heterologous fusion proteins in Gram (-) bacteria and the implications for oral vaccination

Gene

Volumn 221, Issue 1, 1998, Pages 25-34

  Cote Sierra, Javier ^a   Jongert, Erik ^a   Bredan, Amin ^a   Gautam, Dinesh C ^a   Parkhouse, M ^b   Cornelis, Pierre ^a   De Baetselier, Patrick ^a   Revets, Hilde ^a  

^a Parasitol Ultrastructure F   (Belgium)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Foot and mouth disease virus; LacI repressor; Leishmania; Pseudomonas aeruginosa; Salmonella; Surface exposure

Indexed keywords

BACTERIAL VACCINE; HYBRID PROTEIN; LIPOPROTEIN; LIVE VACCINE; OUTER MEMBRANE PROTEIN; SALMONELLOSIS VACCINE;

ARTICLE; BACTERIAL OUTER MEMBRANE; CELL LYSATE; CONTROLLED STUDY; ESCHERICHIA COLI; EXPRESSION VECTOR; GRAM NEGATIVE BACTERIUM; IMMUNOBLOTTING; LEISHMANIA; NONHUMAN; NUCLEOTIDE SEQUENCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROMOTER REGION; PSEUDOMONAS AERUGINOSA; REPRESSOR GENE; SALMONELLA TYPHIMURIUM; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; BACTERIAL PROTEINS; BASE SEQUENCE; BIOLOGICAL TRANSPORT; CAPSID; CAPSID PROTEINS; CELL DIVISION; CLONING, MOLECULAR; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC VECTORS; GRAM-NEGATIVE BACTERIA; ISOPROPYL THIOGALACTOSIDE; LEISHMANIA MAJOR; LIPOPROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTOZOAN PROTEINS; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; SALMONELLA TYPHIMURIUM; VACCINES, SYNTHETIC;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; FOOT-AND-MOUTH DISEASE VIRUS; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; SALMONELLA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0032500768     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(98)00437-5     Document Type: Article

References (36)

1. Agterberg M., Adriaanse H., Barteling S., van Maanen K., Tommassen J. Protection of guinea-pigs against foot-and-mouth disease virus by immunization with a PhoE-FMDV hybrid protein. Vaccine. 8:1990;438-440.
2. Alberti S., Oehler S., von Wilcken-Bergmann B., Krämer H., Müller-Hill B. Dimer-to-tetramer assembly of Lac repressor involves a leucine heptad repeat. New Biol. 3:1991;57-62.
3. Alberti S., Oehler S., von Wilcken-Bergmann B., Müller-Hill B. Genetic analysis of the leucine heptad repeats of Lac repressor: evidence for a 4-helical bundle. EMBO J. 12:1993;3227-3236.
4. Andrews B., Adari H., Hannig G., Lahue E., Gosselin M., Martin S., Ahmed A., Ford P.J., Hayman E.G., Makrides S.C. A tightly regulated high level expression vector that utilizes a thermosensitive lac repressor: production of the human T cell receptor Vb5.3 in Escherichia coli. Gene. 182:1996;101-109.
5. Brenowitz M., Mandal N., Pickar A., Jamison E., Adhya S. DNA-binding properties of a Lac repressor mutant incapable of forming tetramers. J. Biol. Chem. 266:1991;1281-1288.
6. Button L.L., Russell D.G., Klein H.L., Medina-Acosta E., Karess R.E., McMaster W.R. Genes encoding the major surface glycoprotein in Leishmania are tandemly linked at a single chromosomal locus and are constitutively transcribed. Mol. Biochem. Parasitol. 32:1989;271-284.
7. Chakerian A.E., Matthews K.S. Characterization of mutations in oligomerization domain of Lac repressor protein. J. Biol. Chem. 266:1991;22206-22214.
8. Charbit A., Molla A., Saurin W., Hofnung M. Versatility of a vector for expressing foreign polypeptides at the surface of Gram-negative bacteria. Gene. 70:1988;181-189.
9. Cornelis P., Bouia A., Belarbi A., Guyonvarch A., Kammerer B., Hannaert V., Hubert J.C. Cloning and analysis of the gene for the major outer membrane lipoprotein from Pseudomonas aeruginosa. Mol. Microbiol. 3:1989;421-428.
10. Cornelis P., Cote-Sierra J., Lim A. Jr., Malur A., Tungpradabkul S., Tazka H., Leitão A., Martins C.V., diPerna C., Brys L., De Baetselier P., Hamers R. Development of new cloning vectors for the production of immunogenic outer membrane fusion proteins in Escherichia coli. Bio/Technol. 14:1996;203-208.
11. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T., Mowat N. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science. 212:1986;639-641.
12. Doherty A.J., Connolly B.A., Worrall A.F. Overproduction of the toxic protein, bovine pancreatic DNaseI, in Escherichia coli using a tightly controlled T7-promoter-based vector. Gene. 136:1993;337-340.
13. Dunne M., Al-Ramadi B.K., Barthold S.W., Flavel R.A., Fikrig E. Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine lyme borreliosis. Infect. Immun. 63:1995;1611-1614.
14. Everest P., Griffiths P., Dougan G. Live Salmonella vaccines as a route towards oral immunisation. Biologicals. 23:1995;119-124.
15. Fairman R., Chao H.-G., Mueller L., Lavoie T.B., Shen L., Novotny J., Matsueda G.R. Characterization of a new four-chain coiled-coil: Influence of chain length on stability. Protein Sci. 4:1995;1457-1469.
16. Francisco J.A., Earhart C.F., Georgiou G. Transport and anchoring of β-lactamase to the external surface of Escherichia coli. Proc. Nat. Acad. Sci. USA. 89:1992;2713-2717.
17. Friedman A.M., Fischmann T.O., Steitz T.A. Crystal structure of lac repressor core tetramer and its implications for DNA looping. Science. 268:1995;1721-1727.
18. Fuchs P., Breitling F., Dubel S., Seehaus T., Little M. Targeting recombinant antibodies to the surface of Escherichia coli: fusion to a peptidoglycan associated lipoprotein. Biotechnology. 9(12):1991;1369-1372.
19. Georgiou G., Stephens D.L., Stathopoulos C., Poetschke H.L., Mendenhall J., Earhart C.F. Display of β-lactamase on the Escherichia coli surface: outer membrane phenotypes conferred by Lpp′-OmpA′-β-lactamase fusions. Protein Eng. 9:1996;239-247.
20. Georgiou G., Stathopoulos C., Daugherty P.S., Nayak A.R., Iverson B.L., Curtis R. III Display of heterologous proteins on the surface of microoorganisms: From the screening of combinatorial libraries to live recombinant vaccines. Nature Biotech. 15:1997;29-34.
21. qts expression plasmids and evaluation of the thermosensitive lac repressor. Gene. 163:1995;35-40.
22. Hirota Y., Suzuki Y., Yasuda S. On the process of cellular division in Escherichia coli: A mutant of E. coli lacking a murein-lipoprotein. Proc. Nat. Acad. Sci. USA. 74:1977;1417-1420.
23. Hoiseth S.K., Stocker B.A.D. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature. 291:1981;238-239.
24. Kornacker M.G., Pugsley A.P. The normally periplasmic enzyme β-lactamase is specifically and efficiently translocated through the Escherichia coli outer membrane when it is fused to the cell-surface enzyme pullulanase. Mol. Microbiol. 4:1990;1101-1109.
25. Lewis M., Chang G., Horton N.C., Kercher M.A., Pace H.C., Schumacher M.A., Brennan R.G., Lu P. Crystal structure of the lactose operon repressor and its complexes with DNA and inducer. Science. 271:1996;1247-1254.
26. Makrides S. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. 60:1996;512-538.
27. McSorley S., Xu D., Liew F.Y. Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters. Infect. Immun. 65:1997;171-178.
28. Oehler S., Eismann E.R., Krämer H., Müller-Hill B. The three operators of the lac operon cooperate in repression. EMBO J. 9:1990;973-979.
29. Rupper A., Arnold N., Hobom G. OmpA-FMDV VP1 fusion protein: production, cell surface exposure and immune response to the major antigenic domain of foot-and-mouth disease virus. Vaccine. 12:1994;492-498.
30. Schödel F. Prospects for oral vaccination using recombinant bacteria expressing viral epitopes. Adv. Virus Res. 41:1992;409-447.
31. Schorr J., Knapp B., Hundt E., Kupper H.A., Amman E. Surface expression of malarial antigens in Salmonella typhimurium: induction of serum antibody response upon oral vaccination of mice. Vaccine. 9:1991;675-681.
32. Stark M.J.R. Multicopy expression vectors carrying the lac repressor gene for regulated high-level expression of genes in Escherichia coli. Gene. 51:1987;255-267.
33. Suter-Crazzolara C., Unsicker K. Improved expression of toxic proteins in E. coli. BioTechniques. 19:1995;147-149.
34. Wong R.S.Y., Wirtz R.A., Hancock R.E.W. Pseudomonas aeruginosa outer membrane protein OprF as an expression vector for foreign epitopes: the effects of positioning and length on the antigenicity of the epitope. Gene. 158:1995;55-60.
35. Wülfing C., Plückthun A. A versatile and highly repressible Escherichia coli expression system based on invertible promoters: expression of a gene encoding a toxic product. Gene. 136:1993;199-203.
36. Yike I., Zhang Y., Ye J., Dearborn D.G. Expression in Escherichia coli of cytoplasmic portions of the cystic fibrosis transmembrane conductase regulator: apparent bacterial toxicity of peptides containing R-domain sequences. Protein Expres. Purif. 7:1996;45-50.